Total Payments
$2,239
2024 Payments
$51.85
Companies
15
Transactions
224
Medicare Patients
615
Medicare Billing
$134,173
Payment Breakdown by Category
Food & Beverage$2,192 (97.9%)
Education$46.91 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,192 | 223 | 97.9% |
| Education | $46.91 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $404.14 | 31 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $402.17 | 64 | $0 (2019) |
| Alkermes, Inc. | $313.38 | 10 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $292.13 | 62 | $0 (2019) |
| Lundbeck LLC | $230.16 | 14 | $0 (2019) |
| ITI, Inc. | $95.39 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $93.18 | 7 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $82.48 | 5 | $0 (2021) |
| Allergan Inc. | $75.01 | 6 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $59.74 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.85 | 2 | ABBVIE INC. ($51.85) |
| 2023 | $95.39 | 2 | ITI, Inc. ($95.39) |
| 2021 | $23.01 | 1 | Neurocrine Biosciences, Inc. ($23.01) |
| 2020 | $78.87 | 2 | Otsuka America Pharmaceutical, Inc. ($78.87) |
| 2019 | $436.76 | 67 | Teva Pharmaceuticals USA, Inc. ($123.90) |
| 2018 | $1,031 | 100 | Sunovion Pharmaceuticals Inc. ($209.94) |
| 2017 | $522.11 | 50 | Otsuka America Pharmaceutical, Inc. ($141.61) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 02/09/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $48.48 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROLOGY | ||||||
| 03/05/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $64.69 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: CNS | ||||||
| 12/09/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 12/05/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Central Nervous System | ||||||
| 12/05/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: CNS | ||||||
| 12/05/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Central Nervous System | ||||||
| 11/26/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Central Nervous System | ||||||
| 11/19/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Central Nervous System | ||||||
| 11/12/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Central Nervous System | ||||||
| 11/12/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: Central Nervous System | ||||||
| 11/07/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Central Nervous System | ||||||
| 10/31/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: CNS | ||||||
| 10/29/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.73 | General |
| Category: Central Nervous System | ||||||
| 10/22/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: Central Nervous System | ||||||
| 10/15/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Central Nervous System | ||||||
| 10/10/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: CNS | ||||||
| 10/08/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: Central Nervous System | ||||||
| 09/26/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 136 | 608 | $108,495 | $42,800 |
| 2022 | 5 | 147 | 547 | $95,955 | $38,982 |
| 2021 | 7 | 150 | 413 | $70,340 | $30,466 |
| 2020 | 5 | 182 | 406 | $66,139 | $21,925 |
Total Patients
615
Total Services
1,974
Medicare Billing
$134,173
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 283 | $56,600 | $24,339 | 43.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 32 | 164 | $28,700 | $10,524 | 36.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 35 | 131 | $18,995 | $5,954 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 30 | $4,200 | $1,983 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 194 | $38,800 | $17,105 | 44.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 24 | 122 | $21,350 | $8,015 | 37.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 34 | 126 | $18,270 | $6,035 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 84 | $11,760 | $5,242 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 21 | $5,775 | $2,585 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 128 | $25,600 | $12,097 | 47.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 26 | 90 | $15,750 | $6,097 | 38.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 30 | 80 | $11,600 | $4,143 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 56 | $7,840 | $3,766 | 48.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 16 | $4,400 | $2,014 | 45.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $3,600 | $1,546 | 42.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 11 | 31 | $1,550 | $803.54 | 51.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 177 | $38,380 | $10,736 | 28.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 56 | 119 | $13,378 | $6,020 | 45.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 63 | $9,060 | $2,880 | 31.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 12 | 30 | $4,999 | $2,123 | 42.5% |
| 90785 | Interactive complexity | Office | 2020 | 11 | 17 | $320.96 | $166.39 | 51.8% |
About Dr. Susan Haley, M.D
Dr. Susan Haley, M.D is a Psychiatry healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629005186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Haley, M.D has received a total of $2,239 in payments from pharmaceutical and medical device companies, with $51.85 received in 2024. These payments were reported across 224 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,192).
As a Medicare-enrolled provider, Haley has provided services to 615 Medicare beneficiaries, totaling 1,974 services with total Medicare billing of $134,173. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Maumee, OH
- Active Since 06/28/2006
- Last Updated 11/18/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629005186
Products in Payments
- LATUDA (Drug) $402.17
- REXULTI (Drug) $379.12
- AUSTEDO (Drug) $268.78
- Aristada 441 mg (Drug) $256.90
- ABILIFY MAINTENA (Drug) $163.23
- VRAYLAR (Drug) $126.86
- CAPLYTA (Drug) $95.39
- TRINTELLIX (Drug) $91.95
- INGREZZA (Drug) $82.48
- Trintellix (Drug) $68.54
- INVEGA SUSTENNA (Drug) $65.90
- MYDAYIS (Drug) $56.90
- ARISTADA (Drug) $56.48
- Fanapt (Drug) $30.13
- Hetlioz (Drug) $29.61
- SD809-TD (Drug) $23.35
- INVEGA TRINZA (Drug) $14.78
- NUEDEXTA (Drug) $13.52
- SPRAVATO (Drug) $12.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.